Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Mcguire, Philip K.
Cope, Helen
and
Fahy, Thomas A.
1994.
Diversity of Psychopathology Associated with use of 3,4-Methylenedioxymethamphetamine (‘Ecstasy’).
British Journal of Psychiatry,
Vol. 165,
Issue. 3,
p.
391.
Maurer, Hans H.
1996.
On the Metabolism and the Toxicological Analysis of Methylenedioxyphenylalkylamine Designer Drugs by Gas Chromatography-Mass Spectrometry.
Therapeutic Drug Monitoring,
Vol. 18,
Issue. 4,
p.
465.
Ensslin, Hartmut K.
Kovar, Karl-Artur
and
Maurer, Hans H.
1996.
Toxicological detection of the designer drug 3,4-methylenedioxyethylamphetamine (MDE, “Eve”) and its metabolites in urine by gas chromatography — mass spectrometry and fluorescence polarization immunoassay.
Journal of Chromatography B: Biomedical Sciences and Applications,
Vol. 683,
Issue. 2,
p.
189.
Barone, Joseph A.
and
Shermock, Kenneth M.
1997.
Designer Drugs of Abuse.
Journal of Pharmacy Practice,
Vol. 10,
Issue. 4,
p.
292.
Borth, Swantje
H�nsel, Wolfram
R�sner, Peter
and
Junge, Thomas
2000.
Regioisomeric differentiation of 2,3- and 3,4-methylenedioxy ring-substituted phenylalkylamines by gas chromatography/tandem mass spectrometry.
Journal of Mass Spectrometry,
Vol. 35,
Issue. 6,
p.
705.
McGuire, Philip
2000.
Long term psychiatric and cognitive effects of MDMA use.
Toxicology Letters,
Vol. 112-113,
Issue. ,
p.
153.
Cole, J.C.
and
Sumnall, H.R.
2003.
Altered states: the clinical effects of Ecstasy.
Pharmacology & Therapeutics,
Vol. 98,
Issue. 1,
p.
35.
Caudevilla Gálligo, Fernando
2003.
El «éxtasis»: una revisión de la bibliografía científica sobre la 3,4-metilendioximetanfetamina.
Medicina Clínica,
Vol. 120,
Issue. 13,
p.
505.
Ludolph, A. G.
and
Ludolph, A. C.
2005.
Das serotonerge System aus neurologischer und psychiatrischer Sicht.
p.
25.
Baggott, M.J.
Coyle, J.R.
Erowid, E.
Erowid, F.
and
Robertson, L.C.
2011.
Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire.
Drug and Alcohol Dependence,
Vol. 114,
Issue. 1,
p.
61.
Orsolini, Laura
Papanti, Gabriele Duccio
De Berardis, Domenico
Guirguis, Amira
Corkery, John Martin
and
Schifano, Fabrizio
2017.
The “Endless Trip” among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review.
Frontiers in Psychiatry,
Vol. 8,
Issue. ,
eLetters
No eLetters have been published for this article.